Researchers at the University of Luxembourg have identified potential new ways to test for the first signs of one of the most deadly types of cancer: colorectal cancer. They have found new “biomarkers”: molecules whose increased presence or absence in tissue suggests the development of tumorous cells. These indicators could help detect colorectal cancer at an early stage, predict its severity or even offer new treatments.
“Colorectal cancer is still one of the most frequent and deadliest cancers worldwide. But diagnosed in time it can be cured in 9 out of 10 cases”, said Professor Serge Haan from the Life Science Research Unit at the University of Luxembourg.
“Thus it is highly important to identify more sensitive and specific markers to improve early diagnosis as well as therapeutic strategies”.
The research team around Prof. Serge Haan and Dr. Elisabeth Letellier studied over 800 detailed results of tissue-analysis of both patients with various stages of colorectal cancer and healthy individuals.
They completed this study with original analysis of patient material from the Ontario Tumor Bank in Canada and the Integrated Biobank of Luxembourg.
The Luxembourg-based team were the first to see a significant reduction in certain proteins (specifically SOCS2 and SOCS6) in pre-cancerous and cancerous colorectal cells.
They concluded that especially SOCS2 could be a very sensitive, early diagnostic biomarker. Further analysis also revealed that this protein could even give an early prediction of the cancer’s severity.
SOCS stands for “Suppressor Of Cytokine Signalling”, regulatory proteins which are essential for normal cell growth.
There is increasing evidence that the loss of SOCS proteins plays a role in many cancers as this induce uncontrolled cell growth and tumour development. This study additionally strengthens the case for those proteins having tumour repressive potential.
These findings have been published in the renowned British Journal of Cancer. The research team included several Luxembourg biomedical research institutions: The National Health Laboratory, the Santé Public Research Centre and the Integrated Biobank of Luxembourg.
This study was financed by the Luxembourg Cancer Foundation. Further work is now needed to expand on these findings before they can be used clinically.
http://www.nature.com/bjc/journal/v111/n4/abs/bjc2014377a.html - Link to the publication
http://wwwen.uni.lu/recherche/fstc/life_sciences_research_unit - Life Sciences Research Unit at the University of Luxembourg
Sophie Kolb | idw - Informationsdienst Wissenschaft
NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases
Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
19.03.2018 | Physics and Astronomy
19.03.2018 | Materials Sciences
19.03.2018 | Event News